Procaps Gr Stock (NASDAQ: PROC) stock price, news, charts, stock research, profile.
You can purchase shares of Procaps Gr (NASDAQ:PROC) through any online brokerage.
Other companies in Procaps Gr’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Bioage Labs (NASDAQ:BIOA), Neumora Therapeutics (NASDAQ:NMRA) and Aquestive Therapeutics (NASDAQ:AQST).
Procaps Gr has a consensus price target of $4.50.
The stock price for Procaps Gr (NASDAQ: PROC) is $1.7 last updated January 13, 2025 at 9:25 AM EST.
There are no upcoming dividends for Procaps Gr.
Procaps Gr’s Q3 earnings are confirmed for Tuesday, December 26, 2023.
There is no upcoming split for Procaps Gr.
Procaps Gr is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.